Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Int J Tuberc Lung Dis ; 13(2): 153-64, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19146741

RESUMO

This paper summarises tuberculosis (TB) research over almost 30 years in Karonga District, northern Malawi, an area typical of much of rural Africa. The dominant factor has been the human immunodeficiency virus (HIV), which arrived in the district about 1980, leading to an increase in TB incidence to a peak of approximately 65 smear-positive pulmonary cases per 100000 population in 2000. Tuberculin surveys indicate annual risks of Mycobacterium tuberculosis infection of approximately 1%; thus, most of the population is uninfected and at risk of primary infection and disease. Molecular epidemiological studies demonstrate that about two thirds of TB arises from recent infection, but recognisable recent contact is responsible for only about 10% of disease. By 2001, 57% of TB was directly attributable to HIV, implying that it would have declined were it not for HIV. HIV infection increases the risk of TB most among young adults, and greatly increases the risk of recurrence from new infection after treatment. Mortality rates in the HIV-infected are high, but there is no association of HIV with drug resistance. Other risk factors with relatively smaller effects include age and sex, contact, several genetic polymorphisms and area. Neither one nor two doses of the bacille Calmette-Guérin (BCG) vaccine provides protection against adult pulmonary TB, despite protecting against leprosy. Skin test surveys, cohort studies and comparative immunological studies with the UK suggest that exposure to environmental mycobacteria provides some protection against TB and that BCG's failure is attributable partly to this widespread heterologous exposure masking effects of the vaccine. Drug resistance has remained constant (<10%) over more than 20 years. Immunotherapy with M. vaccae provided no benefits, but treatment of HIV-positive patients with cotrimoxazole reduced mortality. The Karonga programme illustrates the value of long-term population-based studies to investigate the natural history of TB and to influence TB control policy. Current studies focus on immunological markers of infection, disease and protection, and on elucidating the impact of antiretroviral treatment on TB incidence at population level.


Assuntos
Mycobacterium tuberculosis , Serviços Preventivos de Saúde/estatística & dados numéricos , Tuberculose Pulmonar/epidemiologia , Tuberculose Pulmonar/microbiologia , Antituberculosos/uso terapêutico , Vacina BCG , Protocolos Clínicos , Comorbidade , Quimioterapia Combinada , Predisposição Genética para Doença , Infecções por HIV/epidemiologia , Infecções por HIV/prevenção & controle , Humanos , Malaui/epidemiologia , Serviços Preventivos de Saúde/métodos , Ensaios Clínicos Controlados Aleatórios como Assunto , Fatores de Risco , Saúde da População Rural/estatística & dados numéricos , Serviços de Saúde Rural , Fatores Sexuais , Tuberculose Resistente a Múltiplos Medicamentos , Tuberculose Pulmonar/genética , Tuberculose Pulmonar/prevenção & controle , Vacinação
3.
Genes Immun ; 5(3): 221-5, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15014432

RESUMO

Leprosy is a chronic disease caused by infection with Mycobacterium leprae, which is manifested across a wide clinical spectrum. There is evidence that susceptibility both to leprosy per se and to the clinical type of leprosy is influenced by host genetic factors. This paper describes the application of an identity by descent regression search for genetic determinants of leprosy type among families from Karonga District, Northern Malawi. Suggestive evidence was found for linkage to leprosy type on chr 21q22 (P<0.001). The methodological implications of the approach and the findings are discussed.


Assuntos
Cromossomos Humanos Par 21/genética , Ligação Genética/genética , Predisposição Genética para Doença , Hanseníase/epidemiologia , Feminino , Humanos , Hanseníase/diagnóstico , Hanseníase/genética , Malaui/epidemiologia , Masculino , Linhagem , Análise de Regressão
4.
Ann Trop Med Parasitol ; 96(2): 137-44, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12080974

RESUMO

In Malawi, two main foci of lymphatic filariasis (LF) are known to exist: one in the south, in the Shire valley, and the other in the north, along the Songwe River, on the border with Tanzania. There have been no formal surveys in the Songwe area since the 1960s but an opportunity arose in 2000-2001 to map LF in this area, in the context of a leprosy survey that formed part of the follow-up of a large leprosy and tuberculosis vaccine trial. Overall 687 immunochromatographic (ICT) tests were carried out. Wuchereria bancrofti antigenaemia was found in > 25% of adults in each of the 12 villages sampled (four in the Songwe area and eight in the rest of the Karonga district), with village prevalences varying from 28%-58%. Of the 685 adult male residents of the Songwe area who were each given full-body clinical examinations, 80 (11.7%) were identified as cases of hydrocele. Lymphoedema was found in seven (1.0%) of these adult males and in 29 (3.7%) of the 769 adult female residents of the Songwe area who were also examined. Microfilariae were detected in 33 (30.8%) of the 107 thick smears of night-blood samples that were made from individuals with positive ICT cards. The W. bancrofti infection focus in Karonga district is therefore wider than was previously known. This has important implications for the implementation and eventual impact of LF-control activities in this area.


Assuntos
Filariose Linfática/epidemiologia , Adolescente , Adulto , Distribuição por Idade , Idoso , Animais , Criança , Doença Crônica , Feminino , Humanos , Linfedema/epidemiologia , Linfedema/parasitologia , Malaui/epidemiologia , Masculino , Microfilárias/isolamento & purificação , Pessoa de Meia-Idade , Prevalência , Hidrocele Testicular/epidemiologia , Hidrocele Testicular/parasitologia
11.
s.l; s.n; 1992. 1 p.
Não convencional em Inglês | SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1236471
12.
s.l; s.n; 1992. 2 p.
Não convencional em Inglês | SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1236450
14.
s.l; s.n; 1991. 1 p.
Não convencional em Inglês | SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1236651
17.
s.l; s.n; 1986. 4 p. tab.
Não convencional em Inglês | SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1234467
18.
s.l; s.n; 1985. 10 p. tab.
Não convencional em Inglês | SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1232049

Assuntos
Hanseníase
19.
In. International Leprosy Congress, 12. International Leprosy Congress, 12/Proceedings. New Delhi, s.n, 1984. p.103-107, tab, graf.
Não convencional em Inglês | LILACS-Express | SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1246366
20.
In. International Leprosy Congress, 12. International Leprosy Congress, 12/Proceedings. New Delhi, s.n, 1984. p.656-665, ilus, graf.
Não convencional em Inglês | LILACS-Express | SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1246473
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA